PREVALENCE OF ANEMIA IN PATIENTS WITH SOLID TUMORS: A SINGLE CENTER CROSS-SECTIONAL STUDY AT A TERTIARY CARE CENTER IN WEST INDIA

G S Chowdhary, Kunal Kishore, Garvit Bagga

Abstract


Background: Anemia is one of the most frequently reported problems in patients with cancer. It is a frequent finding in cancer patients, occurring
in >40% of cases.
Methods: To evaluate the distribution, the main causes, and the possible correlations of anemia with type and stage of cancer in a population of
patients with solid tumors, we carried out a cross sectional observational study on a cohort of 127 subjects.
Results: Anemia was observed in 58.4% of patients, with an increase in the prevalence with increasing age regardless of gender difference. In more
than one-half (59.1% )of anemic patients, anemia was mild. Moderate to severe anemia was seen in 27.6% and 13.4% cases respectively. Iron
deficiency was the commonest etiology for anemia in cases with solid tumors (54.33%) followed by anemia due to chronic disease (41.73%). Mild
anemia was relatively more common in cases with CNS tumors and Breast carcinoma while severe anemia was associated with lymphomas and
colorectal carcinoma.
Conclusion: Our data confirm the high prevalence of anemia in patients hospitalized in an Oncology unit, with a remarkable burden of mild forms,
and of chronic inflammation's pathogenic mechanism. Correlations with comorbidities and duration of hospital stay highlight the crucial part
played by anemia in determining the clinical complexity of such patients.


Full Text:

PDF

References


World Health Organization. Global Burdon of Diseases 2004 update, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland: WHO; 2008.

National Consultation on the Control of Nutritional Anaemia in India. Department of Family Welfare (Maternal Health Division], Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi, 1998.

Seshadri S. A database on iron deficiency anaemia (IDA] in India: prevalence, causes, consequences and strategies for prevention. Department of Foods and Nutrition. WHO Collaborating Centre for Nutrition Research. The Maharaja Sayajirao University of Baroda, Vadodara, India, 1999.

National Family Health Survey (NFHS-4], 2016–17: India: Volume I. Mumbai: IIPS. available on: rchiips.org/NFHS/factsheet_NFHS-4.shtml.

Knight K, Wade S, Balducci L. Prevalence and outcomes of anaemia in cancer: a systematic review of the literature. Am J Med 2004; 116 Suppl 7A: 11S–26S.

NCCN clinical practice guidelines. Cancer- and chemotherapy-induced anemia. V2. 2010. Available at http://www.nccn.org/professionals/physician_gls/PDF/ anemia.pdf.

Toledano A, Luporsi E, Morere JF, Scotté F, Laribi K, Barrière J, Huot-Marchand P, Duvillié L, Concas VH, Bugat R. Clinical use of ferric carboxymaltose in patients with solid tumours or haematological malignancies in France. Supportive Care in Cancer. 2016 Jan 1;24(1):67-75.

Ludwig H, Van Belle S, Barrett-Lee P, Birgegård G, Bokemeyer C, Gascón P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40(15):2293–306.

What is cancer? - Understanding - Macmillan Cancer Support. www.macmillan.org.uk/information-and-support/understanding.../what-is-cancer.html.

Miller CB et al. (1990) Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322: 1689-1692.

Kanuri G, Sawhney R, Varghese J, Britto M, Shet A. Iron Deficiency Anemia Coexists with Cancer Related Anemia and Adversely Impacts Quality of Life. PloS one. 2016 Sep 28;11(9):e0163817.

Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007. Clin Ther. 2009;31:2416-2432.

Cella D (1997) The Functional Assessment of Cancer Therapy—Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34: 13-19.

Xu H, Xu L, Page JH, Cannavale K, Sattayapiwat O, Rodriguez R, Chao C. Incidence of anemia in patients diagnosed with solid tumors receiving chemotherapy, 2010–2013. Clinical epidemiology. 2016;8:61.

Bahl A, Sharma D.N, Basu J,Rath G.K, Julka P.K. Pre-Treatment anemia evaluation in Cancer patients attending Radiotherapy Clinic: Results from a single Indian Center. Indian J Med Sci, 2008.Vol. 62, No. 10.

Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Annals of oncology: official journal of the Euro- pean Society for Medical Oncology / ESMO. 2012; 23(8):1954–62.

Goodnough LT, Nemeth E, Ganz T. Detection evaluation, and management of iron-restricted erythropoiesis. Blood. 2010;116(23):4754–61.

Marks PW, Rosenthal, DS. Hematologic manifestations of systemic disease: infection, chronic inflammation, and cancer. In: Hoffman R, Benz EJ, Shattil SJ, et al, eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, PA: Churchill Livingstone Elsevier. 2009;2309-2319.

Birgegård G, Aapro MS, Bokemeyer C, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology. 2005;68(suppl 1):3-11.


Refbacks

  • There are currently no refbacks.